COMBINES SYNOPSIS SOLICITATION- IPSC DIFFERENTIATI

AI Summary

The National Institutes of Health seeks proposals for scientific support services focused on the quality control of Induced Pluripotent Stem Cells (iPSCs) and their use in organoid generation. This non-competitive solicitation is issued under FAR guidelines and is expected to be awarded as a firm fixed-price contract.

Contract details

Solicitation No.: 75N98026Q00878
Notice Type: Solicitation
Posted Date: July 27, 2026
Response Deadline: July 31, 2026
NAICS Code: 541714 AI guide
PSC / Class Code: Q301
Issuing Office: NATIONAL INSTITUTES OF HEALTH OLAO
Sub-Agency: NATIONAL INSTITUTES OF HEALTH
Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES
Primary Contact: JOHNSON, JOHN R
City: BETHESDA
State: MD
ZIP Code: 20892
AI Product/Service: service

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.

(ii) The solicitation number is 75N98026Q00878/PCA-NIMH-02470. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable).
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Oxford StemTech Ltd The Oxford Science Park Hayakawa Building Edmund Hally Road Oxford, UK to acquire scientific support services for the quality control of Induced Pluripotent Stem Cells (iPSCs) and use of a subset of these iPSC lines for generation and characterization of organoids.

Key dates

July 27, 2026Posted Date
July 31, 2026Proposals / Responses Due

AI search tags

scientific support services quality control induced pluripotent stem cells organoid generation

Frequently asked questions

COMBINES SYNOPSIS SOLICITATION- IPSC DIFFERENTIATI is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.